المؤلفون: Novak, F., Ostergaard, K., Berg, J. Munksgaard, Kristensen, C. Hilt, Illes, Z., Sellebjerg, F., Sejbaek, T.

المصدر: Novak , F , Ostergaard , K , Berg , J M , Kristensen , C H , Illes , Z , Sellebjerg , F & Sejbaek , T 2021 , ' Extended dosage interval of B-cell therapy in multiple sclerosis ' , Multiple Sclerosis Journal , vol. 27 , no. Suppl. 2 , pp. 767 . < https://doi.org/10.1177/13524585211047080 >

الاتاحة: https://portal.findresearcher.sdu.dk/da/publications/f0219333-aa58-4bcb-bb9d-2a2d4154e39f
https://doi.org/10.1177/13524585211047080

المؤلفون: Novak, F., Østergaard, K., Berg, J. Munksgaard, Kristensen, C. Hilt, Illes, Z., Sellebjerg, F., Sejbaek, T.

المصدر: Novak , F , Østergaard , K , Berg , J M , Kristensen , C H , Illes , Z , Sellebjerg , F & Sejbaek , T 2021 , ' Extended dosage interval of B-cell therapy in multiple sclerosis ' , Multiple Sclerosis Journal , vol. 27 , no. Suppl. 2 , P941 , pp. 767 . https://doi.org/10.1177/13524585211047080

الاتاحة: https://vbn.aau.dk/da/publications/ae6bbc6d-46a1-4b91-83e4-5f3be49c77d7
https://doi.org/10.1177/13524585211047080